Takahiro Shima

2.1k total citations
59 papers, 1.5k citations indexed

About

Takahiro Shima is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Takahiro Shima has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 22 papers in Molecular Biology and 17 papers in Immunology. Recurrent topics in Takahiro Shima's work include Acute Myeloid Leukemia Research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Galectins and Cancer Biology (8 papers). Takahiro Shima is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Galectins and Cancer Biology (8 papers). Takahiro Shima collaborates with scholars based in Japan, United States and Mexico. Takahiro Shima's co-authors include Koichi Akashi, Toshihiro Miyamoto, Yoshikane Kikushige, Hiromi Iwasaki, Katsuto Takenaka, Shingo Urata, Shin‐ichiro Takayanagi, Hiroaki Niiro, Takanori Teshima and Goichi Yoshimoto and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Takahiro Shima

52 papers receiving 1.5k citations

Peers

Countries citing papers authored by Takahiro Shima

Since Specialization

Citations

This map shows the geographic impact of Takahiro Shima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Shima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Shima more than expected).

Fields of papers citing papers by Takahiro Shima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiro Shima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Shima. The network helps show where Takahiro Shima may publish in the future.

Co-authorship network of co-authors of Takahiro Shima

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiro Shima. A scholar is included among the top collaborators of Takahiro Shima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiro Shima. Takahiro Shima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cerebrospinal fluid proteomics exerts predictive potential for immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapy 2025 ·Leukemia ·(unknown), Daiki Setoyama, (unknown), (unknown), Kohta Miyawaki, Takuji Yamauchi, (unknown), (unknown), Kensuke Sasaki, Takahiro Shima, Yoshikane Kikushige, Yasuo Mori, Koichi Akashi, Koji Kato, Yuya Kunisaki	0
2	Fatal posterior reversible encephalopathy syndrome after blood transfusion in a patient with myelodysplastic syndromes 2024 ·Transfusion ·(unknown), Takahiro Shima, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Takuro Kuriyama, (unknown), Shuichi Taniguchi, (unknown)	1
3	TIM‐3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation 2024 ·Cancer Science ·(unknown), Yoshikane Kikushige, (unknown), (unknown), (unknown), Yuichiro Semba, (unknown), Takahiro Shima, Yasuo Mori, (unknown), Tomohiko Kamimura, Hiromi Iwasaki, Ryosuke Ogawa, (unknown), Koji Kato, Takahiro Maeda, Toshihiro Miyamoto, (unknown)	0
4	Outcomes of allogeneic stem cell transplantation for patients with hematologic diseases ≥60 years old 2023 ·PubMed ·Takahiro Shima, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Takuro Kuriyama, Tetsuya Eto	2
5	C11orf21, a novel RUNX1 target gene, is down-regulated by RUNX1-ETO 2022 ·SHILAP Revista de lepidopterología ·(unknown), Tatsushi Yoshida, Takahiro Shima, Kenta Yamasaki, Kenjiro Tadagaki, Noriko Kondo, Yasumichi Kuwahara, Dong‐Er Zhang, Tsukasa Okuda	3
6	Panuveitis induced by donor-derived CD8+ T cells after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia 2022 ·American Journal of Ophthalmology Case Reports ·Atsunobu Takeda, (unknown), Nobuyo Yawata, Koji Kato, Eiichi Hasegawa, Takahiro Shima, (unknown), (unknown), (unknown), Yoshinao Oda, Koichi Akashi, (unknown)	0
7	Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation 2021 ·International Journal of Hematology ·(unknown), Yasuo Mori, Goichi Yoshimoto, Takuji Yamauchi, (unknown), Ayano Yurino, (unknown), Junichiro Yuda, Takahiro Shima, Jun Odawara, Shuichiro Takashima, Kenjiro Kamezaki, Koji Kato, Toshihiro Miyamoto, Koichi Akashi, Katsuto Takenaka	2
8	Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody for the Treatment of Multiple Myeloma 2019 ·Molecular Cancer Therapeutics ·Tatsushi Kodama, (unknown), (unknown), Hideaki Mizuno, Takeshi Baba, Kiyoshi Habu, Noriaki Sawada, Hiroyuki Tsunoda, Takahiro Shima, Kohta Miyawaki, Yoshikane Kikushige, Yasuo Mori, Toshihiro Miyamoto, Takahiro Maeda, Koichi Akashi	62
9	Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation 2019 ·Blood ·Samuel A. Stoner, Ming Yan, Katherine Liu, (unknown), Takahiro Shima, Huan‐You Wang, D. T. Johnson, Rafael Bejar, Catriona Jamieson, Kun‐Liang Guan, Dong‐Er Zhang	12
10	Evaluation of the compliance with antiemetic guidelines for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancy. 2019 ·PubMed ·Mayako Uchida, Tsutomu Nakamura, Takahiro Shima, (unknown), Goichi Yoshimoto, (unknown), Mototsugu Shimokawa, Keiko Hosohata, Tatsuki Miyamoto, Koichi Akashi	4
11	Human Herpes Virus-6–Associated Encephalitis/Myelitis Mimicking Calcineurin Inhibitor–Induced Pain Syndrome in Allogeneic Stem Cell Transplantation Recipients 2018 ·Biology of Blood and Marrow Transplantation ·Goichi Yoshimoto, Yasuo Mori, Koji Kato, Takahiro Shima, Kohta Miyawaki, Yoshikane Kikushige, Kenjiro Kamezaki, Akihiko Numata, Takahiro Maeda, Katsuto Takenaka, Hiromi Iwasaki, Takanori Teshima, Koichi Akashi, Toshihiro Miyamoto	7
12	Gastrointestinal Graft-versus-Host Disease Is a Risk Factor for Postengraftment Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients 2018 ·Biology of Blood and Marrow Transplantation ·Yasuo Mori, Goichi Yoshimoto, (unknown), Takeshi Sugio, Kohta Miyawaki, Takahiro Shima, Yoji Nagasaki, Noriko Miyake, (unknown), Yuya Kunisaki, Kenjiro Kamezaki, Akihiko Numata, Koji Kato, Motoaki Shiratsuchi, Takahiro Maeda, Katsuto Takenaka, Hiromi Iwasaki, Nobuyuki Shimono, Koichi Akashi, Toshihiro Miyamoto	26
13	CPSF1 Regulates AML1-ETO Fusion Gene Polyadenylation and Stability in t(8;21) Acute Myelogenous Leukemia 2017 ·Blood ·Takahiro Shima, (unknown), Sayuri Miyauchi, (unknown), D. T. Johnson, Samuel A. Stoner, Junichiro Yuda, Toshihiro Miyamoto, Jiehua Zhou, Edward D. Ball, Koichi Akashi, Dong‐Er Zhang	2
14	Characterization of the Post-Transcriptional Regulation of AML1-ETO Expression in t(8;21) Leukemia Cells 2017 ·Blood ·D. T. Johnson, Takahiro Shima, (unknown), Dong‐Er Zhang	1
15	RUNX1 Deficiency and SRSF2 Mutation Cooperate to Promote Myelodysplastic Syndrome Development 2017 ·Blood ·Yi-Jou Huang, Ming Yan, Eun Hee Kim, (unknown), Takahiro Shima, Sayuri Miyauchi, Xiang‐Dong Fu, Omar Abdel‐Wahab, Dong‐Er Zhang	1
16	Preserved in vivo reconstitution ability of PBSCs cryopreserved for a decade at −80 °C 2015 ·Bone Marrow Transplantation ·Takahiro Shima, Hiromi Iwasaki, Takuji Yamauchi, (unknown), (unknown), (unknown), K Takenaka, Toshihiro Miyamoto, Koichi Akashi, Takanori Teshima	7
17	Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients 2014 ·International Journal of Hematology ·Shuichiro Takashima, Toshihiro Miyamoto, Masanori Kadowaki, Yoshikiyo Ito, Takatoshi Aoki, Ken Takase, Takahiro Shima, Goichi Yoshimoto, Koji Kato, Tsuyoshi Muta, Motoaki Shiratsuchi, Katsuto Takenaka, Hiromi Iwasaki, Takanori Teshima, Tomohiko Kamimura, Koichi Akashi	6
18	The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment 2013 ·Experimental Hematology ·Chika Iwamoto, Katsuto Takenaka, Shingo Urata, Takuji Yamauchi, Takahiro Shima, Takuro Kuriyama, (unknown), Yasuyuki Saito, Toshihiro Miyamoto, Hiromi Iwasaki, Issay Kitabayashi, Katsuhiko Itoh, Junji Kishimoto, Daisuke Kohda, Takashi Matozaki, Koichi Akashi	37
19	Self-Renewing Hematopoietic Stem Cell Is the Primary Target in Pathogenesis of Human Chronic Lymphocytic Leukemia 2011 ·Cancer Cell ·Yoshikane Kikushige, Fumihiko Ishikawa, Toshihiro Miyamoto, Takahiro Shima, Shingo Urata, Goichi Yoshimoto, Yasuo Mori, Tadafumi Iino, Takuji Yamauchi, Tetsuya Eto, Hiroaki Niiro, Hiromi Iwasaki, Katsuto Takenaka, Koichi Akashi	200
20	FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD–specific STAT5 activation 2009 ·Blood ·Goichi Yoshimoto, Toshihiro Miyamoto, Siamak Jabbarzadeh‐Tabrizi, Tadafumi Iino, Jennifer L. Rocnik, Yoshikane Kikushige, Yasuo Mori, Takahiro Shima, Hiromi Iwasaki, Katsuto Takenaka, Koji Nagafuji, Shin-ichi Mizuno, Hiroaki Niiro, Gary Gilliland, Koichi Akashi	200

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact